{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:10:22Z","timestamp":1789506622438,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023280","name":"Seqirus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128934","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:49:48Z","timestamp":1784270988000},"page":"128934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expanding enhanced influenza vaccines programs for adults aged \u226565 in the Nordic region predicted to improve public health and health system resilience"],"prefix":"10.1016","volume":"88","author":[{"given":"Anna","family":"Grootendorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger Sand","family":"Paludan-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"St\u00f8vring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Mould-Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2026.128934_bb0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.exger.2005.04.012","article-title":"Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly","volume":"40","author":"Abedin","year":"2005","journal-title":"Exp. Gerontol."},{"issue":"44\u201346","key":"10.1016\/j.vaccine.2026.128934_bb0010","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1016\/j.vaccine.2006.05.063","article-title":"Real-time monitoring of the influenza vaccine field effectiveness","volume":"24","author":"Legrand","year":"2006","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2026.128934_bb0015","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1016\/j.vaccine.2009.06.032","article-title":"Influenza control in the 21st century: optimizing protection of older adults","volume":"27","author":"Monto","year":"2009","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2026.128934_bb0020","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.39.1800092","article-title":"Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010\/11 to 2016\/17","volume":"23","author":"Pebody","year":"2018","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128934_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.7249\/rhq-10-04-02","article-title":"The societal and indirect economic burden of seasonal influenza in the United Kingdom","volume":"10","author":"Romanelli","year":"2023","journal-title":"Rand Health Q"},{"key":"10.1016\/j.vaccine.2026.128934_bb0030","series-title":"Influenza vaccination 2002\/2003. Epi Nyt","author":"Statens Serum Institut","year":"2002"},{"key":"10.1016\/j.vaccine.2026.128934_bb0035","series-title":"Lagr\u00e5dsremiss: ny ordning f\u00f6r nationella vaccinationsprogram","author":"Lagr\u00e5d","year":"2012"},{"key":"10.1016\/j.vaccine.2026.128934_bb0040","series-title":"Vaksinering i voksen alder: barrierer og drivere sett fra perspektiver til vaksinetilbydere og vaksinemottakere","author":"Nybru Gleditsch","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0045","series-title":"National vaccination program in Finland","author":"Finnish Institute for Health and Welfare","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128934_bb0050","unstructured":"Smittetryk i de dankse regioner - Interaktive dashboards (Influenza A and B, in age groups 65-74, 75-84, 85+, season 2024\/2025) [Internet]. 2025. Available from: https:\/\/experience.arcgis.com\/template\/099eb5c9acea4e18b411997815be2f98."},{"key":"10.1016\/j.vaccine.2026.128934_bb0055","series-title":"Influenza in Sweden \u2013 season 2024\u20132025","author":"The Public Health Agency of Sweden","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0060","series-title":"Influenza virological and epidemiological season report prepared for the WHO consultation on the composition of influenza virus vaccines for the Northern Hemisphere 2026","author":"Norwegian Institute of Public Health","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0065","unstructured":"Inpatient care of acute respiratory tract infections in Finland (THL Cube database) - November 2024 to May 2025 [Internet]. 2025. Available from: https:\/\/sampo.thl.fi\/pivot\/prod\/fi\/epirapo\/respinfcare\/fact_epirapo_respinfcare."},{"key":"10.1016\/j.vaccine.2026.128934_bb0070","series-title":"Vaccinations","first-page":"35","article-title":"Special considerations for vaccines and the elderly","author":"Saade","year":"2019"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128934_bb0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2026.128934_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107983","article-title":"Comparable effectiveness of MF59\u00ae-adjuvanted and high-dose quadrivalent inactivated influenza vaccines for prevention of test-confirmed influenza during the 2022\u20132023 influenza season","volume":"159","author":"Imran","year":"2025","journal-title":"Int. J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.vaccine.2026.128934_bb0085","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.12.2500174","article-title":"Enhanced influenza vaccines impact effectiveness in individuals aged 65 years and older, Denmark, 2024\/25 influenza season up to 4 March 2025","volume":"30","author":"Emborg","year":"2025","journal-title":"Euro Surveill."},{"key":"10.1016\/j.vaccine.2026.128934_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107160","article-title":"Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017\u20132020 influenza seasons","volume":"146","author":"McGovern","year":"2024","journal-title":"Int. J. Infect. Dis."},{"issue":"21","key":"10.1016\/j.vaccine.2026.128934_bb0095","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.vaccine.2017.03.092","article-title":"Efficacy and safety of high-dose influenza vaccine in elderly adults: a systematic review and meta-analysis","volume":"35","author":"Wilkinson","year":"2017","journal-title":"Vaccine"},{"issue":"0","key":"10.1016\/j.vaccine.2026.128934_bb0100","article-title":"High-dose influenza vaccine effectiveness against hospitalization in older adults","volume":"0","author":"Johansen","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2026.128934_bb0105","series-title":"Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over","author":"European Center for Disease Prevention and Control","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128934_bb0110","series-title":"JCVI statement on influenza vaccines for 2025 to 2026","author":"Joint Committee on Vaccination and Immunisation","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0115","unstructured":"Norwegian Institute of Public Health. Vaksinasjonsh\u00e5ndboka 2025 [Available from: https:\/\/www.fhi.no\/va\/vaksinasjonshandboka\/."},{"key":"10.1016\/j.vaccine.2026.128934_bb0120","series-title":"Vaccination mot influensa","author":"The Public Health Agency of Sweden","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0125","series-title":"Bestilling af s\u00e6sonvacciner 2025\u20132026","author":"Statens Serum Institut","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0130","series-title":"Grippe saisonni\u00e8re: la HAS pr\u00e9cise la place des vaccins Efluelda et Fluad dans la strat\u00e9gie vaccinale","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0135","series-title":"Vaccination against seasonal influenza: winter season 2025\u20132026","author":"Hoge Gezondheidsraad","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0140","article-title":"Beschluss zur Anpassung der STIKO-Empfehlung einer Standardimpfung f\u00fcr Personen \u2265 60 Jahre zum Schutz vor Erkrankungen durch saisonale Influenzaviren","volume":"44","author":"St\u00e4ndige Impfkommission","year":"2025","journal-title":"Epidemiol. Bull."},{"key":"10.1016\/j.vaccine.2026.128934_bb0145","series-title":"Prevenzione e controllo dell\u2018influenza: raccomandazioni per la stagione 2025\u20132026","author":"Ministero della Salute","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128934_bb0150","series-title":"R: A language and environment for statistical computing","year":"2021"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128934_bb0155","article-title":"Cost-effectiveness of vaccination of older adults with an MF59(\u00ae)-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in Denmark, Norway, and Sweden","volume":"11","author":"Jacob","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128934_bb0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vaccine.2019.10.021","article-title":"Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults","volume":"38","author":"Essink","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128934_bb0165","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12890-024-03251-y","article-title":"Immediate post-discharge care among US adults hospitalized with respiratory syncytial virus infection","volume":"24","author":"Sato","year":"2024","journal-title":"BMC Pulm Med."},{"key":"10.1016\/j.vaccine.2026.128934_bb0170","series-title":"SYSVAK influensavaksinasjon sesong 2024\/2025 (ukentlig oppdatering) [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0175","series-title":"Determinanter for influenza vaccination af personer \u226565 \u00e5r - s\u00e6son 2022\u20132023","author":"Statens Serum Institut","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128934_bb0180","series-title":"07459: population, by region, age, contents and year - 2025, 1st of January [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0185","series-title":"FOLK1AM: population at the first day of the month by region, sex and age [Internet]","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128934_bb0190","series-title":"Folkm\u00e4ngden per m\u00e5nad efter k\u00f6n, m\u00e5nad, region och \u00e5lder (2025M8) [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0195","series-title":"11re - Population according to age (1-year) and sex by area, 1972\u20132024, 31st of December 2024 [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0200","series-title":"Influenza vaccination coverage by area on a map (season 2024-2025, Week 10) [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0205","series-title":"Influenza vaccination coverage (2023\u20132024) per region (not published, but available at their request)","author":"The Public Health Agency of Sweden","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0210","series-title":"Statistikdatabas f\u00f6r \u00e4ldreomsorg - \u00c4ldreomsorg, Antal, Personer som bor i permanent s\u00e4rskilt boende, Riket, b\u00e5da k\u00f6nen (2025) [Internet]","year":"2025"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128934_bb0215","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.128934_bb0220","series-title":"Life table (2 years tables) by life table, time, age and sex (2023\u20132024) [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0225","series-title":"07902: life tables, by age x, contents, year and gender (Life expectancy - remaining years at age x, 2024) [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0230","series-title":"Life table by sex and age. Year 1960\u20132024. Observed expectation of life at age by year, sex, and age (2024) [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0235","series-title":"12ap - Life table by age and sex, 1986\u20132024. Life expectancy, years (2024) [Internet]","year":"2025"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128934_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5731","article-title":"Exploring changes to resident thriving and associated factors in Swedish nursing homes: a repeated cross-sectional study","volume":"37","author":"Baxter","year":"2022","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.vaccine.2026.128934_bb0245","series-title":"Honorartabel - overenskomst om almen praksis (1. april 2025 til 1. oktober 2025)","author":"Praktiserende L\u00e6gers Organisation","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0250","series-title":"DRG-masterliste [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0255","series-title":"NordDRG 2025: prospective hospital weights for inpatient and outpatient groups in somatics [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0260","series-title":"InteraktivDRG [Internet]","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0265","series-title":"Enhetskostnader V1.5 [Internet]","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128934_bb0270","series-title":"Innsatsstyrt finansiering regelverk","author":"Helsedirektoratet","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0275","series-title":"Regional prices and reimbursements for the Southern Healthcare Region","author":"Southern Regional Health Care Board","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0280","series-title":"Terveyden- ja sosiaalihuollon yksikk\u00f6kustannukset Suomessa vuonna 2017 (Unit costs of health and social care in Finland 2017)","author":"Finnish Institute for Health and Welfare","year":"2021"},{"key":"10.1016\/j.vaccine.2026.128934_bb0285","series-title":"Medicinpriser.dk","author":"L\u00e6gemiddelstyrelsen","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0290","series-title":"Legemiddels\u00f8k","author":"Direktoratet for medisinke produkter","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0295","series-title":"Euro foreign exchange reference rates","author":"European Central Bank","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128934_bb0300","series-title":"Inzet van vernieuwde typen griepvaccines in het NPG","author":"Gezondheidsraad","year":"2024"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128934_bb0305","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.vaccine.2018.04.063","article-title":"Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis","volume":"36","author":"Somes","year":"2018","journal-title":"Vaccine"},{"issue":"19 [\u200efull issue]\u200e","key":"10.1016\/j.vaccine.2026.128934_bb0310","article-title":"Vaccines against influenza: WHO position paper \u2013 May 2022","volume":"97","author":"WHO","year":"2022","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.vaccine.2026.128934_bb0315","series-title":"Key facts about seasonal flu vaccine","author":"CDC","year":"2025"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128934_bb0320","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/13696998.2023.2194193","article-title":"Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal","volume":"26","author":"Alvarez","year":"2023","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.vaccine.2026.128934_bb0325","first-page":"1","article-title":"High one-year mortality following intensive care among adults with influenza A(H1N1)pdm09, A(H3N2), or B in Southern Sweden: a retrospective observational study","author":"Jaffer Broman","year":"2026","journal-title":"Infect. Dis. Ther."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128934_bb0330","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/13696998.2024.2314429","article-title":"Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study","volume":"27","author":"Hu","year":"2024","journal-title":"J. Med. Econ."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128934_bb0335","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/irv.12719","article-title":"Characteristics of hospitalizations with an influenza diagnosis, France, 2012\u20132013 to 2016-2017 influenza seasons","volume":"14","author":"Pivette","year":"2020","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.vaccine.2026.128934_bb0340","article-title":"Impact of influenza related hospitalization in Spain: characteristics and risk factor of mortality during five influenza seasons (2016 to 2021)","volume":"12\u20132024","author":"Ramos-Rinc\u00f3n","year":"2024","journal-title":"Front. Public Health"},{"key":"10.1016\/j.vaccine.2026.128934_bb0345","series-title":"11xb - consumer price index (2015=100), monthly data, 2015M01-2025M09 [Internet]","year":"2025"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26007437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:32:24Z","timestamp":1789504344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26007437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":69,"alternative-id":["S0264410X26007437"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128934","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding enhanced influenza vaccines programs for adults aged \u226565 in the Nordic region predicted to improve public health and health system resilience","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128934"}}